Preclinical profile of antitumor activity of a novel hydrophilic camptothecin, ST1968
- 1 July 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 7 (7) , 2051-2059
Abstract
ST1968 is a novel hydrophilic camptothecin (CPT) derivative of the 7-oxyiminomethyl series. Because ST1968 retained ability to form remarkably stable cleavable complexes, this study was done to investigate its preclinical profile of antitumor activity in a large panel of human tumor models, including irinotecan-resistant tumors. Although less potent than SN38 in vitro, i.v. administered ST1968 caused a marked tumor inhibition, superior to that of irinotecan, in most tested models. ST1968 exhibited an impressive activity against several tumors including models of ovarian and colon carcinoma in which a high rate of cures was observed. In the most responsive tumors, complete and persistent tumor regressions were achieved even with low suboptimal doses. Even tumors derived from intrinsically resistant cells exhibited a significant responsiveness. Histologic analysis of treated tumors supports a contribution of both proapoptotic and antiangiogenic effects to ST1968 antitumor efficacy. A study done in yeast cells transformed with CPT-resistant mutant forms of topoisomerase I documented that, in contrast to other tested CPT, ST1968 was active against yeasts expressing the mutant K720E enzyme. Based on its outstanding efficacy superior to that of irinotecan and of its good therapeutic index, ST1968 has been selected for clinical development. [Mol Cancer Ther 2008;7(7):2051–9]Keywords
This publication has 30 references indexed in Scilit:
- Relevance of extracellular and intracellular interactions of camptothecins as determinants of antitumor activityBiochemical Pharmacology, 2007
- Alterations in Linker Flexibility Suppress DNA Topoisomerase I Mutant-induced Cell LethalityJournal of Biological Chemistry, 2007
- Propionyl-L-carnitine Reduces Proliferation and Potentiates Bax-related Apoptosis of Aortic Intimal Smooth Muscle Cells by Modulating Nuclear Factor-κB ActivityJournal of Biological Chemistry, 2007
- Topoisomerase I inhibitors: camptothecins and beyondNature Reviews Cancer, 2006
- Mechanisms of Camptothecin Resistance by Human Topoisomerase I MutationsJournal of Molecular Biology, 2004
- Single Mutation in the Linker Domain Confers Protein Flexibility and Camptothecin Resistance to Human Topoisomerase IJournal of Biological Chemistry, 2003
- Camptothecin and Its AnalogsAnnals of the New York Academy of Sciences, 1996
- Preclinical Antitumor Activity and Pharmacokinetics of Irinotecan (CPT‐11) in Tumor‐bearing MiceAnnals of the New York Academy of Sciences, 1996
- A new force field for molecular mechanical simulation of nucleic acids and proteinsJournal of the American Chemical Society, 1984
- AMBER: Assisted model building with energy refinement. A general program for modeling molecules and their interactionsJournal of Computational Chemistry, 1981